Replies to post #81948 on Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

AXAL may yield some revenue sooner than NEO/HOT, but in the long run NEO and HOT are likely to be much more valuable. I don't believe for a minute that AXAL is the most valuable construct, the market has spoken pretty clearly on that one.

[ignatiusrielly35]

I think the chances that NEO and HOT are not at least as good as AXAL are slim. After all, they are based on AXAL.

[jckrdu]

Tj - I was fully expecting to see KB announce the wind-down of AXAL/cervical in the last quarterly results PR that was issued at the same time as the recent offering. My thought was: If KB is going to wind-down AXAL/Cervical, he'll get ALL the bad news out at the same time (disastrous offering with warrants, wind-down AXAL/Cervical), thus ripping the band-aid off with one pull, and then moving on.

Makes little sense to me to release very bad news twice, instead of once.

Recent guidance is that they're still "seeking a partner" for AXAL/Cervical. Hopefully KB succeeds.